Risk Management



Fluorescein Angiography: Preventing and Responding to Complications

Fluorescein angiography (FA) is a diagnostic procedure. A photographer takes a rapid sequence of photographs of the blood vessels in the retina and choroid (the back of the eye). The dye is usually injected into a vein in the arm, forearm, or hand. While generally well tolerated, angiography is an invasive procedure with risks. The most severe risk, while rare, is of a life-threatening allergic reaction. Here are some risk management recommendations to help you and your staff members prevent and better respond to the risks of the procedure. Issues addressed in Fluorescein Angiography Recommendations and Consent include delegation of tasks, informed consent, emergency response equipment, and management of complications.

See this document by using the download button above.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.

61864684